Those results also confirmed the fact that TGFBR2 and TGFBI genes were highly expressed in MSS not because of the Hypoxia/hypoxia-inducible factor signaling pathway but because of the potential inhibition of TGFβ signaling pathway in MSI subtype colon cancer patients. The gene discussed is TGFBI; the disease is colonic neoplasm.